Global Metabolic Syndrome Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
- GLO2773799
- 139 Pages
- September 2018
- Medical Devices
Scope of the Report:
This report studies the Metabolic Syndrome market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Metabolic Syndrome market by product type and applications/end industries.
One of the upcoming trends gaining traction in the market is the increasing focus on oral insulin therapies. Till now, insulin injections were mostly administered through subcutaneous tissues, but this route of application is associated with risk of infection and hypersensitivity reactions, emboli, high cost, and injection site pain. Also, several needle-phobic individuals hesitate to adopt this route of administration. This paved the way for extensive research in the development of oral insulin. The oral form of insulin prevents the unpleasantness of insulin injections and other complications associated with the existing therapies. Moreover, oral administration of insulin ensures increased patient comfort and compliance, reduced risk of infection, simpler application, and is cost-effective.
The global Metabolic Syndrome market is valued at 24600 million USD in 2017 and is expected to reach 33400 million USD by the end of 2023, growing at a CAGR of 5.2% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Metabolic Syndrome.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Novo Nordisk
Sanofi
Merck
AstraZeneca
Eli Lily
AbbVie
Actelion Pharmaceuticals
Adocia
Aegerion Pharmaceuticals
Akros Pharma
Alnylam Pharmaceuticals
Amarin
nAmgen
Amicus Therapeutics
Arbutus Biopharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Diabetes
Obesity
Hypercholesterolemia
Lysosomal storage diseases
Market Segment by Applications, can be divided into
Hospital
Clinic
Others
1 Metabolic Syndrome Market Overview
1.1 Product Overview and Scope of Metabolic Syndrome
1.2 Classification of Metabolic Syndrome by Types
1.2.1 Global Metabolic Syndrome Revenue Comparison by Types (2017-2023)
1.2.2 Global Metabolic Syndrome Revenue Market Share by Types in 2017
1.2.3 Diabetes
1.2.4 Obesity
1.2.5 Hypercholesterolemia
1.2.6 Lysosomal storage diseases
1.3 Global Metabolic Syndrome Market by Application
1.3.1 Global Metabolic Syndrome Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Metabolic Syndrome Market by Regions
1.4.1 Global Metabolic Syndrome Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Metabolic Syndrome Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Metabolic Syndrome Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Metabolic Syndrome Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Metabolic Syndrome Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Metabolic Syndrome Status and Prospect (2013-2023)
1.5 Global Market Size of Metabolic Syndrome (2013-2023)
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Business Overview
2.1.2 Metabolic Syndrome Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novo Nordisk Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sanofi
2.2.1 Business Overview
2.2.2 Metabolic Syndrome Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
2.3.1 Business Overview
2.3.2 Metabolic Syndrome Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.4 AstraZeneca
2.4.1 Business Overview
2.4.2 Metabolic Syndrome Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 AstraZeneca Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.5 Eli Lily
2.5.1 Business Overview
2.5.2 Metabolic Syndrome Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Eli Lily Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.6 AbbVie
2.6.1 Business Overview
2.6.2 Metabolic Syndrome Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AbbVie Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.7 Actelion Pharmaceuticals
2.7.1 Business Overview
2.7.2 Metabolic Syndrome Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Actelion Pharmaceuticals Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.8 Adocia
2.8.1 Business Overview
2.8.2 Metabolic Syndrome Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Adocia Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.9 Aegerion Pharmaceuticals
2.9.1 Business Overview
2.9.2 Metabolic Syndrome Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Aegerion Pharmaceuticals Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.10 Akros Pharma
2.10.1 Business Overview
2.10.2 Metabolic Syndrome Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Akros Pharma Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.11 Alnylam Pharmaceuticals
2.11.1 Business Overview
2.11.2 Metabolic Syndrome Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Alnylam Pharmaceuticals Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.12 Amarin
2.12.1 Business Overview
2.12.2 Metabolic Syndrome Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Amarin Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.13 nAmgen
2.13.1 Business Overview
2.13.2 Metabolic Syndrome Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 nAmgen Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.14 Amicus Therapeutics
2.14.1 Business Overview
2.14.2 Metabolic Syndrome Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Amicus Therapeutics Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.15 Arbutus Biopharma
2.15.1 Business Overview
2.15.2 Metabolic Syndrome Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Arbutus Biopharma Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
3 Global Metabolic Syndrome Market Competition, by Players
3.1 Global Metabolic Syndrome Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Metabolic Syndrome Players Market Share
3.2.2 Top 10 Metabolic Syndrome Players Market Share
3.3 Market Competition Trend
4 Global Metabolic Syndrome Market Size by Regions
4.1 Global Metabolic Syndrome Revenue and Market Share by Regions
4.2 North America Metabolic Syndrome Revenue and Growth Rate (2013-2018)
4.3 Europe Metabolic Syndrome Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Metabolic Syndrome Revenue and Growth Rate (2013-2018)
4.5 South America Metabolic Syndrome Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Metabolic Syndrome Revenue and Growth Rate (2013-2018)
5 North America Metabolic Syndrome Revenue by Countries
5.1 North America Metabolic Syndrome Revenue by Countries (2013-2018)
5.2 USA Metabolic Syndrome Revenue and Growth Rate (2013-2018)
5.3 Canada Metabolic Syndrome Revenue and Growth Rate (2013-2018)
5.4 Mexico Metabolic Syndrome Revenue and Growth Rate (2013-2018)
6 Europe Metabolic Syndrome Revenue by Countries
6.1 Europe Metabolic Syndrome Revenue by Countries (2013-2018)
6.2 Germany Metabolic Syndrome Revenue and Growth Rate (2013-2018)
6.3 UK Metabolic Syndrome Revenue and Growth Rate (2013-2018)
6.4 France Metabolic Syndrome Revenue and Growth Rate (2013-2018)
6.5 Russia Metabolic Syndrome Revenue and Growth Rate (2013-2018)
6.6 Italy Metabolic Syndrome Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Metabolic Syndrome Revenue by Countries
7.1 Asia-Pacific Metabolic Syndrome Revenue by Countries (2013-2018)
7.2 China Metabolic Syndrome Revenue and Growth Rate (2013-2018)
7.3 Japan Metabolic Syndrome Revenue and Growth Rate (2013-2018)
7.4 Korea Metabolic Syndrome Revenue and Growth Rate (2013-2018)
7.5 India Metabolic Syndrome Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Metabolic Syndrome Revenue and Growth Rate (2013-2018)
8 South America Metabolic Syndrome Revenue by Countries
8.1 South America Metabolic Syndrome Revenue by Countries (2013-2018)
8.2 Brazil Metabolic Syndrome Revenue and Growth Rate (2013-2018)
8.3 Argentina Metabolic Syndrome Revenue and Growth Rate (2013-2018)
8.4 Colombia Metabolic Syndrome Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Metabolic Syndrome by Countries
9.1 Middle East and Africa Metabolic Syndrome Revenue by Countries (2013-2018)
9.2 Saudi Arabia Metabolic Syndrome Revenue and Growth Rate (2013-2018)
9.3 UAE Metabolic Syndrome Revenue and Growth Rate (2013-2018)
9.4 Egypt Metabolic Syndrome Revenue and Growth Rate (2013-2018)
9.5 Nigeria Metabolic Syndrome Revenue and Growth Rate (2013-2018)
9.6 South Africa Metabolic Syndrome Revenue and Growth Rate (2013-2018)
10 Global Metabolic Syndrome Market Segment by Type
10.1 Global Metabolic Syndrome Revenue and Market Share by Type (2013-2018)
10.2 Global Metabolic Syndrome Market Forecast by Type (2018-2023)
10.3 Diabetes Revenue Growth Rate (2013-2023)
10.4 Obesity Revenue Growth Rate (2013-2023)
10.5 Hypercholesterolemia Revenue Growth Rate (2013-2023)
10.6 Lysosomal storage diseases Revenue Growth Rate (2013-2023)
11 Global Metabolic Syndrome Market Segment by Application
11.1 Global Metabolic Syndrome Revenue Market Share by Application (2013-2018)
11.2 Metabolic Syndrome Market Forecast by Application (2018-2023)
11.3 Hospital Revenue Growth (2013-2018)
11.4 Clinic Revenue Growth (2013-2018)
11.5 Others Revenue Growth (2013-2018)
12 Global Metabolic Syndrome Market Size Forecast (2018-2023)
12.1 Global Metabolic Syndrome Market Size Forecast (2018-2023)
12.2 Global Metabolic Syndrome Market Forecast by Regions (2018-2023)
12.3 North America Metabolic Syndrome Revenue Market Forecast (2018-2023)
12.4 Europe Metabolic Syndrome Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Metabolic Syndrome Revenue Market Forecast (2018-2023)
12.6 South America Metabolic Syndrome Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Metabolic Syndrome Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Metabolic Syndrome Picture
Table Product Specifications of Metabolic Syndrome
Table Global Metabolic Syndrome and Revenue (Million USD) Market Split by Product Type
Figure Global Metabolic Syndrome Revenue Market Share by Types in 2017
Figure Diabetes Picture
Figure Obesity Picture
Figure Hypercholesterolemia Picture
Figure Lysosomal storage diseases Picture
Table Global Metabolic Syndrome Revenue (Million USD) by Application (2013-2023)
Figure Metabolic Syndrome Revenue Market Share by Applications in 2017
Figure Hospital Picture
Figure Clinic Picture
Figure Others Picture
Table Global Market Metabolic Syndrome Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Metabolic Syndrome Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Metabolic Syndrome Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Metabolic Syndrome Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Metabolic Syndrome Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Metabolic Syndrome Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Metabolic Syndrome Revenue (Million USD) and Growth Rate (2013-2023)
Table Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk Metabolic Syndrome Type and Applications
Table Novo Nordisk Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Metabolic Syndrome Type and Applications
Table Sanofi Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Metabolic Syndrome Type and Applications
Table Merck Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Metabolic Syndrome Type and Applications
Table AstraZeneca Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lily Basic Information, Manufacturing Base and Competitors
Table Eli Lily Metabolic Syndrome Type and Applications
Table Eli Lily Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Metabolic Syndrome Type and Applications
Table AbbVie Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
Table Actelion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Actelion Pharmaceuticals Metabolic Syndrome Type and Applications
Table Actelion Pharmaceuticals Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
Table Adocia Basic Information, Manufacturing Base and Competitors
Table Adocia Metabolic Syndrome Type and Applications
Table Adocia Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
Table Aegerion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Aegerion Pharmaceuticals Metabolic Syndrome Type and Applications
Table Aegerion Pharmaceuticals Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
Table Akros Pharma Basic Information, Manufacturing Base and Competitors
Table Akros Pharma Metabolic Syndrome Type and Applications
Table Akros Pharma Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Alnylam Pharmaceuticals Metabolic Syndrome Type and Applications
Table Alnylam Pharmaceuticals Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
Table Amarin Basic Information, Manufacturing Base and Competitors
Table Amarin Metabolic Syndrome Type and Applications
Table Amarin Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
Table nAmgen Basic Information, Manufacturing Base and Competitors
Table nAmgen Metabolic Syndrome Type and Applications
Table nAmgen Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
Table Amicus Therapeutics Basic Information, Manufacturing Base and Competitors
Table Amicus Therapeutics Metabolic Syndrome Type and Applications
Table Amicus Therapeutics Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
Table Arbutus Biopharma Basic Information, Manufacturing Base and Competitors
Table Arbutus Biopharma Metabolic Syndrome Type and Applications
Table Arbutus Biopharma Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2017)
Table Global Metabolic Syndrome Revenue (Million USD) by Players (2013-2018)
Table Global Metabolic Syndrome Revenue Share by Players (2013-2018)
Figure Global Metabolic Syndrome Revenue Share by Players in 2016
Figure Global Metabolic Syndrome Revenue Share by Players in 2017
Figure Global Top 5 Players Metabolic Syndrome Revenue Market Share in 2017
Figure Global Top 10 Players Metabolic Syndrome Revenue Market Share in 2017
Figure Global Metabolic Syndrome Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Metabolic Syndrome Revenue (Million USD) by Regions (2013-2018)
Table Global Metabolic Syndrome Revenue Market Share by Regions (2013-2018)
Figure Global Metabolic Syndrome Revenue Market Share by Regions (2013-2018)
Figure Global Metabolic Syndrome Revenue Market Share by Regions in 2017
Figure North America Metabolic Syndrome Revenue and Growth Rate (2013-2018)
Figure Europe Metabolic Syndrome Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Metabolic Syndrome Revenue and Growth Rate (2013-2018)
Figure South America Metabolic Syndrome Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Metabolic Syndrome Revenue and Growth Rate (2013-2018)
Table North America Metabolic Syndrome Revenue by Countries (2013-2018)
Table North America Metabolic Syndrome Revenue Market Share by Countries (2013-2018)
Figure North America Metabolic Syndrome Revenue Market Share by Countries (2013-2018)
Figure North America Metabolic Syndrome Revenue Market Share by Countries in 2017
Figure USA Metabolic Syndrome Revenue and Growth Rate (2013-2018)
Figure Canada Metabolic Syndrome Revenue and Growth Rate (2013-2018)
Figure Mexico Metabolic Syndrome Revenue and Growth Rate (2013-2018)
Table Europe Metabolic Syndrome Revenue (Million USD) by Countries (2013-2018)
Figure Europe Metabolic Syndrome Revenue Market Share by Countries (2013-2018)
Figure Europe Metabolic Syndrome Revenue Market Share by Countries in 2017
Figure Germany Metabolic Syndrome Revenue and Growth Rate (2013-2018)
Figure UK Metabolic Syndrome Revenue and Growth Rate (2013-2018)
Figure France Metabolic Syndrome Revenue and Growth Rate (2013-2018)
Figure Russia Metabolic Syndrome Revenue and Growth Rate (2013-2018)
Figure Italy Metabolic Syndrome Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Metabolic Syndrome Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Metabolic Syndrome Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Metabolic Syndrome Revenue Market Share by Countries in 2017
Figure China Metabolic Syndrome Revenue and Growth Rate (2013-2018)
Figure Japan Metabolic Syndrome Revenue and Growth Rate (2013-2018)
Figure Korea Metabolic Syndrome Revenue and Growth Rate (2013-2018)
Figure India Metabolic Syndrome Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Metabolic Syndrome Revenue and Growth Rate (2013-2018)
Table South America Metabolic Syndrome Revenue by Countries (2013-2018)
Table South America Metabolic Syndrome Revenue Market Share by Countries (2013-2018)
Figure South America Metabolic Syndrome Revenue Market Share by Countries (2013-2018)
Figure South America Metabolic Syndrome Revenue Market Share by Countries in 2017
Figure Brazil Metabolic Syndrome Revenue and Growth Rate (2013-2018)
Figure Argentina Metabolic Syndrome Revenue and Growth Rate (2013-2018)
Figure Colombia Metabolic Syndrome Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Metabolic Syndrome Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Metabolic Syndrome Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Metabolic Syndrome Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Metabolic Syndrome Revenue Market Share by Countries in 2017
Figure Saudi Arabia Metabolic Syndrome Revenue and Growth Rate (2013-2018)
Figure UAE Metabolic Syndrome Revenue and Growth Rate (2013-2018)
Figure Egypt Metabolic Syndrome Revenue and Growth Rate (2013-2018)
Figure Nigeria Metabolic Syndrome Revenue and Growth Rate (2013-2018)
Figure South Africa Metabolic Syndrome Revenue and Growth Rate (2013-2018)
Table Global Metabolic Syndrome Revenue (Million USD) by Type (2013-2018)
Table Global Metabolic Syndrome Revenue Share by Type (2013-2018)
Figure Global Metabolic Syndrome Revenue Share by Type (2013-2018)
Figure Global Metabolic Syndrome Revenue Share by Type in 2017
Table Global Metabolic Syndrome Revenue Forecast by Type (2018-2023)
Figure Global Metabolic Syndrome Market Share Forecast by Type (2018-2023)
Figure Global Diabetes Revenue Growth Rate (2013-2018)
Figure Global Obesity Revenue Growth Rate (2013-2018)
Figure Global Hypercholesterolemia Revenue Growth Rate (2013-2018)
Figure Global Lysosomal storage diseases Revenue Growth Rate (2013-2018)
Table Global Metabolic Syndrome Revenue by Application (2013-2018)
Table Global Metabolic Syndrome Revenue Share by Application (2013-2018)
Figure Global Metabolic Syndrome Revenue Share by Application (2013-2018)
Figure Global Metabolic Syndrome Revenue Share by Application in 2017
Table Global Metabolic Syndrome Revenue Forecast by Application (2018-2023)
Figure Global Metabolic Syndrome Market Share Forecast by Application (2018-2023)
Figure Global Hospital Revenue Growth Rate (2013-2018)
Figure Global Clinic Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global Metabolic Syndrome Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Metabolic Syndrome Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Metabolic Syndrome Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Metabolic Syndrome Revenue Market Forecast (2018-2023)
Figure Europe Metabolic Syndrome Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Metabolic Syndrome Revenue Market Forecast (2018-2023)
Figure South America Metabolic Syndrome Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Metabolic Syndrome Revenue Market Forecast (2018-2023)
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
